<DOC>
	<DOCNO>NCT01211197</DOCNO>
	<brief_summary>The objective current study determine relative bioavailability BI 10773 / metformin fix dose combination tablet compare single tablet BI 10773 metformin administer together assess effect food bioavailability fix dose combination tablet</brief_summary>
	<brief_title>Bioavailability Fixed Dose Combination Tablet With Empagliflozin ( BI 10773 ) Metformin Compared With Monocomponents Effect Food Bioavailability</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Empagliflozin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Inclusion criterion : 1 . Healthy male female accord follow criterion 2 . Body Mass Index 18.5 29.9 kg/m2 ( incl . ) Exclusion criterion : 1 . Any finding medical examination ( include Blood Pressure , Pulse Rate electrocardiogram ) deviate normal clinical relevance 2 . Any evidence clinically relevant concomitant disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>